Beamtree Holdings Limited
Beamtree Holdings Limited
Your view on BMT.AX
Overview
What the company does, where it operates, and who runs it.
About Beamtree Holdings Limited
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Marek Stepniak
- Headquarters
- 5 Blue Street, North Sydney, NSW, AU
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Marek Stepniak
- Headquarters
- 5 Blue Street, North Sydney, NSW, AU
Headquartered in Redfern, Australia, Beamtree Holdings Limited, founded in 1996, develops and markets cutting-edge clinical decision support (CDS) solutions for the healthcare sector, both within Australia and globally. The company offers a diverse range of products aimed at improving operational accuracy and patient outcomes.
Among these are RippleDown Expert, providing live patient monitoring and notification capabilities, and RippleDown Auditor, which automates real-time data verification to ensure precision in billing, data entry, and specimen reception while identifying potential errors.
Beamtree also offers PICQ, a quality assessment tool for clinically coded data used by public and private hospitals, health services, and state health authorities, alongside RISQ, designed for the measurement, benchmarking, and management of hospital-acquired complications.
Further expanding its suite, the Q Coding Platform delivers an end-to-end workflow for clinical coding, grouping, reporting, and auditing, supported by Codexpert, a digital reference application for classification information in patient records.
Additionally, the company provides expert advisory and auditing services, such as desktop analysis, data maturity assessments, and physical audits, reaching its clientele through strategic channel partners. The company adopted its current name, Beamtree Holdings Limited, in August 2021, having previously been known as PKS Holdings Limited.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Beamtree Holdings Limited. Starting points for Beamtree Holdings Limited: EPS -AUD 0.06, beta 1.29 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Beamtree Holdings Limited. Beamtree Holdings Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Beamtree Holdings Limited. Trailing twelve-month EPS for Beamtree Holdings Limited stands at -AUD 0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrDec 2026 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|
| Avg. estimate | AUD 0.00 | −AUD 0.00 | AUD 0.00 |
| Low estimate | AUD 0.00 | −AUD 0.00 | AUD 0.00 |
| High estimate | AUD 0.00 | −AUD 0.00 | AUD 0.00 |
| No. of analysts | 0 | 1 | 1 |
| Year-ago EPS | — | −AUD 0.061 | — |
| Growth | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|
| Avg. estimate | AUD 14.66M | AUD 29.00M | AUD 32.30M |
| Low estimate | AUD 14.66M | AUD 29.00M | AUD 32.30M |
| High estimate | AUD 14.66M | AUD 29.00M | AUD 32.30M |
| No. of analysts | 1 | 1 | 1 |
| Year-ago revenue | — | AUD 29.19M | — |
| Growth | — | −0.7% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Beamtree Holdings Limited. Beamtree Holdings Limited has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| VHIBFVitalhub Corp. | Healthcare | OTC | $359.8M | ||
| VHL.AXVitasora Health Limited | Healthcare | ASX | — | ||
| VRHIVeri Medtech Holdings Inc. | Healthcare | OTC | $20.0M | ||
| VSEEVSee Health, Inc. | Healthcare | NASDAQ | $816,478 | ||
| VYNDVynleads, Inc. | Healthcare | OTC | $7.1M | ||
| WAYWaystar Holding Corp. | Healthcare | NASDAQ | $5.3B | ||
| WLSSWelsis Corp. | Healthcare | OTC | $12.7M | ||
| WMGRWellness Matrix Group, Inc. | Healthcare | OTC | $36,250 | ||
| XSVTXsovt Brands, Inc. | Healthcare | OTC | $6,690 | ||
| ZCMDZhongchao Inc. | Healthcare | NASDAQ | $15,047 | ||
| PASOPatient Access Solutions, Inc. | Healthcare | OTC | $74,059 | ||
| PCK.AXPainChek Limited | Healthcare | ASX | — | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Beamtree Holdings Limited. Coverage tracks Beamtree Holdings Limited within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Beamtree Holdings Limited.